首页 | 本学科首页   官方微博 | 高级检索  
     

调肝理脾方治疗腹泻型肠易激综合征及对患者血浆血管活性肠肽 神经肽水平的影响
引用本文:康美清. 调肝理脾方治疗腹泻型肠易激综合征及对患者血浆血管活性肠肽 神经肽水平的影响[J]. 辽宁中医杂志, 2008, 35(11): 1717-1718
作者姓名:康美清
作者单位:漯河医学高等专科学校第三附属医院,河南漯河462002
摘    要:目的:观察调肝理脾方治疗腹泻型肠易激综合征(D-IBS)患者的临床疗效及对患者血浆血管活性肠肽(VIP)、神经肽(NPY)水平影响。方法:92例患者随机分为两组(各46例),治疗组采用调肝理脾方治疗,对照组采用得舒特治疗,疗程结束后观察和评价患者疗效情况,及治疗前后血浆VIP、NPY水平变化,另选30例体检健康者作正常对照。结果:治疗组总有效率91.30%,疗效优于对照组(72.61%)(P<0.05),血浆VIP、NPY水平在治疗组治疗前后比较有显著性差异(P<0.05),在对照组治疗前后比较差异无统计学意义(P>0.05)。结论:调肝理脾方对D-IBS有较好的近期疗效,能调节血浆VIP、NPY分泌异常情况。

关 键 词:腹泻型肠易激综合征  调肝理脾  血管活性肠肽  神经肽Y

Clinical Observation on Treatment of Diarrhea-predominant Irritable Bowel Syndrome with Tiaoganlipifang and Study of the Level of VIP NPY in Serum
KANG Mei-qing. Clinical Observation on Treatment of Diarrhea-predominant Irritable Bowel Syndrome with Tiaoganlipifang and Study of the Level of VIP NPY in Serum[J]. Liaoning Journal of Traditional Chinese Medicine, 2008, 35(11): 1717-1718
Authors:KANG Mei-qing
Affiliation:KANG Mei-qing (The Third Affiliated Hospital of Luohe Medical College,Luohe 462002,Henan,China)
Abstract:Objective: To observe the clinical efficacy Tiaoganlipifang on Diarrhea-predominant Irritable Bowel Syndrome and Study of the level of VIP,NPY in serum.Methods:92 patients with D-IBS were randomly divided into 2 groups,every group has 46 cases.The treatement group were treated with Tiaoganlipifang,the control group were treated with Dicetel,the therapeutic course for all groups was 6 weeks.The clinical efficacy was observed and evaluated after treatment.The change of VIP,NPY in serum after treatment was con...
Keywords:D-IBS  Tiaoganlipifang  VIP  NPY  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号